Información: Esta es una versión obsoleta del modelo de datos. En la sección izquierda, bajo "Versiones", se encuentra el historial de versiones. Puede acceder a la versión actual a través del siguiente link: here.
Información:
Error:
ID
18232
Descripción
The Use of Dendritic Cell/Tumor Fusions as a Novel Tumor Vaccine in Patients With Multiple Myeloma; ODM derived from: https://clinicaltrials.gov/show/NCT00459069
Link
https://clinicaltrials.gov/show/NCT00459069
Palabras clave
Versiones (2)
- 25/10/16 25/10/16 -
- 26/10/16 26/10/16 -
Subido en
25 de octubre de 2016
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 3.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Eligibility Multiple Myeloma NCT00459069
Eligibility Multiple Myeloma NCT00459069
- StudyEvent: Eligibility
Similar models
Eligibility Multiple Myeloma NCT00459069
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Multiple Myeloma | Staging | Patients Clinical Stable | Prior Chemotherapy Quantity
Item
confirmed diagnosis of multiple myeloma: stage i not requiring initiation of chemotherapy; stage i, ii or iii patients felt to be clinically stable and having received at least one prior chemotherapy regimen
boolean
C0026764 (UMLS CUI [1])
C0332305 (UMLS CUI [2])
C0030705 (UMLS CUI [3,1])
C0205210 (UMLS CUI [3,2])
C0205360 (UMLS CUI [3,3])
C1514457 (UMLS CUI [4,1])
C1265611 (UMLS CUI [4,2])
C0332305 (UMLS CUI [2])
C0030705 (UMLS CUI [3,1])
C0205210 (UMLS CUI [3,2])
C0205360 (UMLS CUI [3,3])
C1514457 (UMLS CUI [4,1])
C1265611 (UMLS CUI [4,2])
Measurable Disease | Plasma High M-component | High M-component In Urine | Serum Free kappa light chain | Serum Free lambda light chain
Item
measurable disease as defined by a history of an elevated m component in plasma or urine or free kappa.lambda light chains in serum
boolean
C1513041 (UMLS CUI [1])
C0032105 (UMLS CUI [2,1])
C3151542 (UMLS CUI [2,2])
C3151542 (UMLS CUI [3,1])
C0042037 (UMLS CUI [3,2])
C0229671 (UMLS CUI [4,1])
C0443743 (UMLS CUI [4,2])
C0229671 (UMLS CUI [5,1])
C0443744 (UMLS CUI [5,2])
C0032105 (UMLS CUI [2,1])
C3151542 (UMLS CUI [2,2])
C3151542 (UMLS CUI [3,1])
C0042037 (UMLS CUI [3,2])
C0229671 (UMLS CUI [4,1])
C0443743 (UMLS CUI [4,2])
C0229671 (UMLS CUI [5,1])
C0443744 (UMLS CUI [5,2])
Age
Item
18 years of age or older
boolean
C0001779 (UMLS CUI [1])
ECOG performance status | Life Expectancy
Item
ecog performance status of 0-1 with a greater than nine week life expectancy
boolean
C1520224 (UMLS CUI [1])
C0023671 (UMLS CUI [2])
C0023671 (UMLS CUI [2])
Bone Marrow Involvement Percentage | Plasmacytoma Amenable Excision Under anesthesia Local
Item
> 20% bone marrow involvement or plasmacytoma amenable to resection under local anesthesia
boolean
C1517677 (UMLS CUI [1,1])
C0439165 (UMLS CUI [1,2])
C0032131 (UMLS CUI [2,1])
C3900053 (UMLS CUI [2,2])
C0728940 (UMLS CUI [2,3])
C1720436 (UMLS CUI [2,4])
C0205276 (UMLS CUI [2,5])
C0439165 (UMLS CUI [1,2])
C0032131 (UMLS CUI [2,1])
C3900053 (UMLS CUI [2,2])
C0728940 (UMLS CUI [2,3])
C1720436 (UMLS CUI [2,4])
C0205276 (UMLS CUI [2,5])
Laboratory Results Study Protocol Adequate
Item
laboratory results within ranges outlined in protocol
boolean
C1254595 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
C0205411 (UMLS CUI [1,3])
C2348563 (UMLS CUI [1,2])
C0205411 (UMLS CUI [1,3])
Pregnancy test negative | Contraceptive methods
Item
negative pregnancy test and adequate contraception method(s) must be documented
boolean
C0427780 (UMLS CUI [1])
C0700589 (UMLS CUI [2])
C0700589 (UMLS CUI [2])
Venous Thromboembolism Clinical Significance
Item
history of clinically significant venous thromboembolism
boolean
C1861172 (UMLS CUI [1,1])
C2826293 (UMLS CUI [1,2])
C2826293 (UMLS CUI [1,2])
Immunotherapy | Cell Collection Resulting in Vaccine Generation
Item
received other immunotherapy treatment in the past 4 weeks prior to the initiation of cell collections for vaccine generation
boolean
C0021083 (UMLS CUI [1])
C0007634 (UMLS CUI [2,1])
C0200345 (UMLS CUI [2,2])
C0332294 (UMLS CUI [2,3])
C0042210 (UMLS CUI [2,4])
C3146294 (UMLS CUI [2,5])
C0007634 (UMLS CUI [2,1])
C0200345 (UMLS CUI [2,2])
C0332294 (UMLS CUI [2,3])
C0042210 (UMLS CUI [2,4])
C3146294 (UMLS CUI [2,5])
Chemotherapy Regimen | Therapeutic radiology procedure
Item
chemotherapy or radiation therapy 4 weeks prior to the first vaccine
boolean
C0392920 (UMLS CUI [1])
C1522449 (UMLS CUI [2])
C1522449 (UMLS CUI [2])
Autoimmune Disease Clinical Significance
Item
clinically significant autoimmune disease
boolean
C0004364 (UMLS CUI [1,1])
C2826293 (UMLS CUI [1,2])
C2826293 (UMLS CUI [1,2])
HIV Seropositivity
Item
hiv positive
boolean
C0019699 (UMLS CUI [1])
Illness Serious
Item
serious intercurrent illness
boolean
C0221423 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C0205404 (UMLS CUI [1,2])
systemic steroids | Investigational New Drugs
Item
taking systemic corticosteroids within 4 weeks of treatment with study drug
boolean
C2825233 (UMLS CUI [1])
C0013230 (UMLS CUI [2])
C0013230 (UMLS CUI [2])